Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)

SHA:688189 Revenue

Hunan Nucien Pharmaceutical had revenue of 30.00M CNY in the quarter ending June 30, 2026, with 41.35% growth. This brings the company's revenue in the last twelve months to 136.13M, up 38.56% year-over-year. In the year 2025, Hunan Nucien Pharmaceutical had annual revenue of 141.93M, down -43.62%. That makes Hunan Nucien Pharmaceutical the world's 33,714th largest company by revenue and 5,087th in China.

• Revenue (ttm): 136.13M
• Revenue Growth: +38.56%
• P/S Ratio: 12.91
• Revenue / Employee: 491.43K
• Employees: 277
• Market Cap: 1.76B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	141.93M	-109.79M	-43.62%
Dec 31, 2024	251.72M	-468.34M	-65.04%
Dec 31, 2023	720.06M	21.24M	3.04%
Dec 31, 2022	698.83M	-44.83M	-6.03%
Dec 31, 2021	743.66M	-285.48M	-27.74%

Data Source: S&P Global Market Intelligence Last updated: Aug 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 6, 2026

Data Sources Report a data error